![The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ecdd5f624a5c9ed7cb3cbb34a95a53b6aefc001c/3-Table2-1.png)
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar
![2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml 2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml](https://clinmedjournals.org/articles/iauc/iauc-4-041-001.gif)
2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml
![Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine. Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.](https://cyberleninka.org/viewer_images/859140/f/1.png)
Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.
Significance of the -2propsa Index and the Prostate Health Index in Patients with Prostate Cancer: a Literature Review and Data
![−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text −2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12894-016-0131-0/MediaObjects/12894_2016_131_Fig1_HTML.gif)
−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text
![PDF] Benefit of determining [-2]proPSA levelS in the differentiAl diAgnoSiS of ProStAte cAncer | Semantic Scholar PDF] Benefit of determining [-2]proPSA levelS in the differentiAl diAgnoSiS of ProStAte cAncer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/152575b7ecbc06103db794abc801a0c147ff1ab7/3-Table1-1.png)
PDF] Benefit of determining [-2]proPSA levelS in the differentiAl diAgnoSiS of ProStAte cAncer | Semantic Scholar
![PD06-02 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF PROSTATE VOLUME-ADJUSTED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER PD06-02 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF PROSTATE VOLUME-ADJUSTED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER](https://www.auajournals.org/cms/asset/b82c4691-1dfb-40fa-bedf-10d1e2804576/fx1.jpg)
PD06-02 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF PROSTATE VOLUME-ADJUSTED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER
![2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases 2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2013.50/MediaObjects/41391_2014_Article_BFpcan201350_Fig2_HTML.jpg)